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Background
Resistance against chemotherapeutics is still a major
problem in cancer therapy. One of the mechanisms of
multidrug resistance is up-regulation of ATP-binding
cassette (ABC) transporters. HMG-CoA reductase inhibi-
tors have been shown to directly inhibit the main repre-
sentative, ABCB1 (P-glycoprotein). We have previously
shown in rhabdomyosarcoma (RD) and neuroblastoma
(SH-SY5Y) cells that simvastatin enhanced the intrinsic
apoptotic potential of the anthracycline doxorubicin
[1,2]. The aim of the study presented here is to investi-
gate the long-term effect of simvastatin on the expression
of ABC-transporters in order to evaluate an adjuvant
therapeutic potential of statins in chemotherapy.
Methods
FACS analysis was performed to quantify the accumula-
tion of doxorubicin in RD cells in combinations with
simvastatin or verapamil. Several ABC transporters were
analysed on mRNA and protein level using real-time
PCR and Western blotting in human RD and SH-SY5Y
cells. The endogenous level of ABC transporters was
also investigated from the livers of simvastatin treated
mice.
Results
Here we show that simvastatin led to enhanced accu-
mulation of doxorubicin in RD cells. This was compar-
able to the effect which was observed for the
coadministration of verapamil, a first generation
ABCB1 inhibitor, with doxorubicin. ABCB1 was moni-
tored by Western blot analysis of RD and SH-SY5Y
cells upon continuous application of simvastatin. In a
time and concentration-dependent manner the ABCB1
transporter was less expressed in both cell lines. Inter-
estingly, real-time PCRs revealed a compensatory ele-
vation of mRNAs for various ABC transporters
(ABCB1, ABCC1, ABCC6 and ABCG2). Moreover, the
augmented mRNA levels of ABCB1 do not result in
more transporters on protein level. In vivo,t h ed o w n -
regulation of ABCB1 was confirmed in the liver of
simvastatin-treated mice.
Conclusions
Based on our findings, we conclude that simvastatin is
able to directly inhibit ABC transporters immediately,
but also leads to a long-term down-regulation of various
transporters. This feature makes simvastatin a promising
candidate for adjuvant chemotherapy to impair
transporter-mediated multidrug resistance.
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